SNY News and Press, Sanofi From 01/25/26

2026-01-25 08:07:03 ET As the earnings season gains momentum, the upcoming week is set to deliver one of the most closely watched stretches of earnings season, with heavyweight reporters spanning technology, autos, consumer goods, defense, financials, energy, real estate, and travel. ....

2026-01-21 14:50:39 ET The last time I spoke about Corvus Pharmaceuticals, Inc. ( CRVS ), it was in a Seeking Alpha article entitled " Corvus Pharmaceuticals: Positive Phase 1 Soquelitinib Trial Data Brings 2025 Catalysts. " With respect to this article, I noted that the company...

2026-01-20 11:39:10 ET More on Pfizer, Merck, etc. Pfizer: Rebound Has Just Started Pfizer: The Most Intriguing Value Play Of 2026 GSK plc (GSK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Novavax rises after licensing deal with Pfize...

2026-01-20 09:29:04 ET More on Corvus Pharmaceuticals Corvus Pharmaceuticals: Moving Slowly Forward Corvus Pharmaceuticals, Inc. (CRVS) Q3 2025 Earnings Call Transcript Corvus outlines January data readout for soquelitinib extension study as Phase II atopic dermatiti...

2026-01-20 06:03:22 ET More on AstraZeneca, Unilever, etc. 44th Annual J.P. Morgan Healthcare Conference AstraZeneca PLC (AZN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Sanofi (SAN:CA) Presents at 44th Annual J.P. Morgan Healthcare Conferen...

2026-01-19 11:16:02 ET More on Oakmark Global Select Fund Investor Class Oakmark Global Select Fund Q4 2025 Commentary Seeking Alpha’s Quant Rating on Oakmark Global Select Fund Investor Class Dividend scorecard for Oakmark Global Select Fund Investor Class ...

2026-01-16 13:31:18 ET The last time I spoke about Shattuck Labs ( STTK ) it was in a prior Seeking Alpha article entitled " Shattuck Labs: Positive Blood Cancer Data Leads To Mid-2024 Catalyst ". With respect to this article, I mentioned that the company had released so...

2026-01-16 08:10:52 ET The iShares MSCI France ETF ( EWQ ) currently sits at the intersection of two very distinct narratives: (1) France faces well-known fiscal, political, and productivity challenges; and (2) EWQ's largest constituents are globally diversified companies whose earn...

2026-01-16 04:15:04 ET UBS analyst issues NEUTRAL recommendation for SNY on January 16, 2026 09:35AM ET. The previous analyst recommendation was Buy. SNY was trading at $47.47 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analys...

2026-01-15 11:47:30 ET Thesis: Sanofi readies a second attempt Read the full article on Seeking Alpha For further details see: Why Sanofi May Need To Top $2.4 Billion For Ocular Therapeutix